AI tool could revolutionize skin cancer detection in family clinics

NCT ID NCT06932172

Recruiting now Diagnosis Sponsor: Linkoeping University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an AI system called Dermalyser that helps primary care doctors decide if a skin spot might be cancer. About 3,000 adults in five countries will take part. Doctors in some clinics will use the AI tool, while others will follow standard care. The goal is to see if AI can catch more skin cancers early and reduce unnecessary biopsies or specialist visits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin cancer skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SKIN CANCER

Contacts and locations

Locations

Ekholmen Primary Healthcare Centre
RECRUITING

Linköping, 589 29, Sweden
Finspång Primary Healthcare Centre
RECRUITING

Finspång, Docent, 61230, Sweden
Kärna Primary Care Centre
RECRUITING

Linköping, Docent, 58662, Sweden
Mjölby Primary Care Centre
RECRUITING

Mjölby, Docent, 59530, Sweden
Skärvet Primary Healthcare Centre
RECRUITING

Vaxjo, Docent, 35234, Sweden
Valla Primary Healthcare Centre
RECRUITING

Linköping, Docent, 58213, Sweden
Vikbolandet Primary Care Centre
RECRUITING

Norrköping, Docent, 61024, Sweden
Åby Primary Healthcare Centre
RECRUITING

Norrköping, Docent, 61330, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.